1371623-08-3

Basic information

• Product Name: (R)-5-cyclopentyl-4-ethyl-1-methyl-7-(5-phenylpyridazin-4-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine
• Synonyms: (R)-5-cyclopentyl-4-ethyl-1-methyl-7-(5-phenylpyridazin-4-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine
• CAS NO: 1371623-08-3
• Molecular Weight: 438.535
• Mol File: 1371623-08-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-5-cyclopentyl-4-ethyl-1-methyl-7-(5-phenylpyridazin-4-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-5-cyclopentyl-4-ethyl-1-methyl-7-(5-phenylpyridazin-4-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine(1371623-08-3)
• EPA Substance Registry System: (R)-5-cyclopentyl-4-ethyl-1-methyl-7-(5-phenylpyridazin-4-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine(1371623-08-3)

Safety Data

• Hazardous Substances Data: 1371623-08-3(Hazardous Substances Data)

Upstream product

• 1371615-79-0 (R)-7-chloro-5-cyclopentyl-4-ethyl-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine 
• 536-74-3 phenylacetylene 
• 290-96-0 s-Tetrazine 
• 1371623-10-7 C₂₃H₂₄N₆ 

Relevant articles and documents

INHIBITORS OF POLO-LIKE KINASE

The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U1, U2, U3, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.